TECTONIC THERAPEUTIC INC (TECX) Stock Analyst Ratings
USA - NASDAQ:TECX - US8789721086 - Common Stock
19.32 USD
+0.33 (+1.74%)
18.94 USD
-0.38 (-1.97%)
ChartMill assigns a Buy % Consensus number of 84% to TECX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 81.35. This target is 321.04% above the current price.
TECX was analyzed by 15 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about TECX.
In the previous month the buy percentage consensus was at a similar level.
TECX was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-03 | Oppenheimer | Initiate | Outperform |
| 2025-07-21 | Truist Securities | Initiate | Buy |
| 2025-06-11 | Raymond James | Reiterate | Outperform |
| 2025-06-06 | LifeSci Capital | Initiate | Outperform |
| 2025-05-15 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-04-21 | Mizuho | Initiate | Outperform |
| 2025-03-21 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-01-31 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-20 | Raymond James | Initiate | Outperform |
| 2024-11-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-11 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-08-22 | Wells Fargo | Initiate | Overweight |
| 2024-07-24 | Leerink Partners | Initiate | Outperform |
| 2024-06-26 | Piper Sandler | Initiate | Overweight |
| 2024-06-24 | TD Cowen | Initiate | Buy |
TECTONIC THERAPEUTIC INC / TECX FAQ
What is the price target for TECX stock?
15 analysts have analysed TECX and the average price target is 81.35 USD. This implies a price increase of 321.04% is expected in the next year compared to the current price of 19.32.
What is the consensus rating for TECX stock?
The consensus rating for TECTONIC THERAPEUTIC INC (TECX) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.